INFLUENZA B VIRUS - ANVISA Registration 80213250124

Access comprehensive regulatory information for INFLUENZA B VIRUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80213250124 and manufactured by R-BIOPHARM AG. The registration is held by PHAREBEE DIAGNOSTICOS COMERCIO IMPORTACAO E EXPORTACAO DE PRODUTOS LTDA with validity until Nov 28, 2025.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including NOVATEC IMMUNDIAGNOSTICA GMBH, INSTITUT VIRION\SERION GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.